SECsense Logo

Cyclo Therapeutics, Inc. 8-K Report: Key Stock Insights & Updates

$CYTH
Form 8-K
Filed on: 2025-01-13
Source
Cyclo Therapeutics, Inc. 8-K Report: Key Stock Insights & Updates

Based on the provided section of the financial report, here are the key insights extracted:

  1. Entity Identification:
  • Company Name: Cyclo Therapeutics, Inc.
  • CIK (Central Index Key): 0000922247
  • IRS Employer Identification Number (EIN): 59-3029743
  • Address: 6714 NW 16th Street, Suite B, Gainesville, FL 32653
  • Contact Number: 386-418-8060
  1. Filing Details:
  • Filing Type: 8-K
  • Filing Date: January 10, 2025
  • SEC File Number: 001-39780
  1. Stock Information:
  • Common Stock: The company has common stock with a par value of $0.0001 per share.
  • Ticker Symbol: CYTH (Common Stock), listed on NASDAQ.
  • Warrants: There are also warrants to purchase common stock, with the ticker symbol CYTHW, listed on NASDAQ.
  1. Report Context:
  • The report includes specific dimensions related to stock classes, indicating a categorization of stock and warrants that may be relevant for investors or analysts reviewing the company's capital structure.
  1. Period of Reporting:
  • The reporting period referenced is January 10, 2025, which may suggest the company is providing information regarding a specific event or update relevant to that date.

Summary:

This section provides essential information about Cyclo Therapeutics, Inc., including its stock structure, warrants, and filing details with the SEC. The presence of specific stock and warrant classes is crucial for investors assessing the company's financial instruments.